A randomized double blind comparison of short-term duodenally administrated whale and seal blubber oils in patients with inflammatory bowel disease and joint pain

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 5-6, 2009, Pages 425-432

  Bjørkkjær, Tormod ^a,b   Araujo, Pedro ^a   Madland, Tor Magne ^b,c   Berstad, Arnold ^b,c   Frøyland, Livar ^a  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Arthritis; Inflammatory bowel disease; Joint pain; Long chain n 3 polyunsaturated fatty acids; Prostaglandin E2; Quality of life; Seal oil; Short term duodenal administration; Visual analogue scale; Whale oil

Indexed keywords

ARACHIDONIC ACID; AUROTHIOMALATE; AZATHIOPRINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ICOSAPENTAENOIC ACID; LONG CHAIN FATTY ACID; MESALAZINE; METHOTREXATE; NATURAL PRODUCT; NONSTEROID ANTIINFLAMMATORY AGENT; POLYUNSATURATED FATTY ACID; PREDNISOLONE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SALAZOSULFAPYRIDINE; SEAL OIL; SOYBEAN OIL; UNCLASSIFIED DRUG; WHALE OIL;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; ENTERITIS; ENZYME INHIBITION; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; NAUSEA; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEAL; SHORT COURSE THERAPY; VISUAL ANALOG SCALE; WHALE;

ADULT; ANIMALS; ARTHRALGIA; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DUODENUM; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; OILS; PILOT PROJECTS; SEALS, EARLESS; TIME FACTORS; WHALES;

CETACEA;

EID: 71749101040     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.07.005     Document Type: Article

References (54)

1. Orchard T.R., Wordsworth B.P., and Jewell D.P. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42 (1998) 387-391
2. Palm O., Bernklev T., Moum B., and Gran J.T. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J. Rheumatol. 32 (2005) 1755-1759
3. Calder P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol. Nutr. Food Res. 52 (2008) 885-897
4. Langford R.M., and Mehta V. Selective cyclooxygenase inhibition: its role in pain and anaesthesia. Biomed. Pharmacother. 60 (2006) 323-328
5. Guslandi M. Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?. World J. Gastroenterol. 12 (2006) 1509-1510
6. Fitzcharles M.A., Almahrezi A., and Shir Y. Pain: understanding and challenges for the rheumatologist. Arthritis Rheum. 52 (2005) 3685-3692
7. Dyerberg J., Bang H.O., Stoffersen E., Moncada S., and Vane J.R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet 2 (1978) 117-119
8. Bang H.O., Dyerberg J., and Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med. Scand. 200 (1976) 69-73
9. Horrobin D.F. Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both?. Med. Hypotheses 22 (1987) 421-428
10. Kromann N., and Green A. Epidemiological studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950-1974. Acta Med. Scand. 208 (1980) 401-406
11. Akiba S., Murata T., Kitatani K., and Sato T. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol. Pharm. Bull. 23 (2000) 1293-1297
12. Cleland L.G., and James M.J. Marine oils for antiinflammatory effect-time to take stock. J. Rheumatol. 33 (2006) 207-209
13. Osterud B., Elvevoll E., Barstad H., et al. Effect of marine oils supplementation on coagulation and cellular activation in whole blood. Lipids 30 (1995) 1111-1118
14. Yoshida H., Kumamaru J., Mawatari M., et al. Lymphatic absorption of seal and fish oils and their effect on lipid metabolism and eicosanoid production in rats. Biosci. Biotechnol. Biochem. 60 (1996) 1293-1298
15. Vognild E., Elvevoll E.O., Brox J., et al. Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans. Lipids 33 (1998) 427-436
16. Small D.M. The effects of glyceride structure on absorption and metabolism. Annu. Rev. Nutr. 11 (1991) 413-434
17. Kew S., Wells S., Thies F., et al. The effect of eicosapentaenoic acid on rat lymphocyte profiferation depends upon its position in dietary triacylglycerols. J. Nutr. 133 (2003) 4230-4238
18. Huntjens D.R., Danhof M., and Della Pasqua O.E. Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors. Rheumatology (Oxford) 44 (2005) 846-859
19. Goldberg R.J., and Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 129 (2007) 210-223
20. Arslan G., Brunborg L.A., Froyland L., Brun J.G., Valen M., and Berstad A. Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids 37 (2002) 935-940
21. Bjorkkjaer T., Brun J.G., Valen M., et al. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids Health Dis. 5 (2006) 6
22. Bjorkkjaer T., Brunborg L.A., Arslan G., et al. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand. J. Gastroenterol. 39 (2004) 1088-1094
23. Osterud B., and Elvevoll E.O. The combination of virgin olive oils and refined marine oils: beneficial effects. Prog. Nutr. 10 (2008) 230-236
24. Brunborg L.A., Madland T.M., Lind R.A., Arslan G., Berstad A., and Froyland L. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil. Clin. Nutr. 27 (2008) 614-622
25. Gregersen K., Lind R.A., Bjorkkjaer T., Froyland L., Berstad A., and Arslan Lied G. Effects of seal oil on meal-induced symptoms and gastric accommodation in patients with subjective food hypersensitivity: a pilot study. Clin. Med. Gastroenterol. 1 (2008) 33-41
26. Cleland L.G., James M.J., and Proudman S.M. Fish oil: what the prescriber needs to know. Arthritis Res. Ther. 8 (2006) 202
27. Fuchs H.A., and Pincus T. Reduced joint counts in controlled clinical trials in rheumatoid arthritis. Arthritis Rheum. 37 (1994) 470-475
28. Scott J., and Huskisson E.C. Graphic representation of pain. Pain 2 (1976) 175-184
29. Harvey R.F., and Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet 1 (1980) 514
30. Walmsley R.S., Ayres R.C., Pounder R.E., and Allan R.N. A simple clinical colitis activity index. Gut 43 (1998) 29-32
31. Lundberg J.O., Hellstrom P.M., Fagerhol M.K., Weitzberg E., and Roseth A.G. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2 (2005) 96-102
32. Arslan G., Lind R., Olafsson S., Florvaag E., and Berstad A. Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia Index. Dig. Dis. Sci. 49 (2004) 680-687
33. Lie O., and Lambertsen G. Fatty acid composition of glycerophospholipids in seven tissues of cod (Gadus morhua), determined by combined high-performance liquid chromatography and gas chromatography. J. Chromatogr. 565 (1991) 119-129
34. Araujo P., Bjorkkjaer T., Berstad A., and Froyland L. Improved quantification of prostaglandins in biological samples by optimizing simultaneously the relationship eicosanoid/internal standard and using liquid chromatography tandem mass spectrometry. Prostaglandins Leukot. Essent. Fatty Acids 77 (2007) 9-13
35. Araujo P., and Froyland L. Optimisation of an extraction method for the determination of prostaglandin E2 in plasma using experimental design and liquid chromatography tandem mass spectrometry. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 830 (2006) 212-217
36. Moren M., Opstad I., and Hamre K. A comparison of retinol, retinal and retinyl ester concentrations in larvae of Atlantic halibut (Hippoglossus hippoglossus L.) fed Artemia or zooplankton. Aquaculture Nutr 10 (2004) 253-259
37. Noll G.N. High-performance liquid chromatographic analysis of retinal and retinol isomers. J. Chromatogr. A 721 (1996) 247-259
38. 3 in fish meals by HPLC. Fisk Dir. Skr. Ser Ernær. 6 (1994) 163-175
39. CEN: Foodstuffs-determination of vitamin E by high performance liquid chromatography-measurement of alpha-, beta-, gamma-, and delta-tocopherols (prEN 12822), 1999.
40. Hamre K., Naess T., Espe M., Holm J.C., and Lie O. A formulated diet for Atlantic halibut (Hippoglossus hippoglossus) larvae. Aquaculture Nutr. 7 (2001) 123-132
41. Schmedes A., and Holmer G. A new thiobarbituric acid (TBA) method for determining free malondialdehyde (MDA) and hydroperoxides selectively as a measure of lipid peroxidation. JAOCS 66 (1989) 813-817
42. Madland T.M., Bjorkkjaer T., Brunborg L.A., Froyland L., Berstad A., and Brun J.G. Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil. J. Rheumatol. 33 (2006) 307-310
43. Tracey K.J. Fat meets the cholinergic antiinflammatory pathway. J. Exp. Med. 202 (2005) 1017-1021
44. Hekmatdoost A., Feizabadi M.M., Djazayery A., et al. The effect of dietary oils on cecal microflora in experimental colitis in mice. Indian J. Gastroenterol. 27 (2008) 186-189
45. Stremmel W., Ehehalt R., Autschbach F., and Karner M. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann. Intern. Med. 147 (2007) 603-610
46. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., and Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N. Engl. J. Med. 334 (1996) 1557-1560
47. Hillier K., Jewell R., Dorrell L., and Smith C.L. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 32 (1991) 1151-1155
48. Trebble T.M., Arden N.K., Wootton S.A., et al. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am. J. Clin. Nutr. 80 (2004) 1137-1144
49. Panganamala R.V., and Cornwell D.G. The effects of vitamin E on arachidonic acid metabolism. Ann. NY Acad. Sci. 393 (1982) 376-391
50. Romanato G., Scarpa M., Angriman I., et al. Plasma lipids and inflammation in active inflammatory bowel diseases. Aliment Pharmacol. Ther. 29 (2009) 298-307
51. Whelan J. Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits. J. Nutr. 139 (2009) 5-10
52. Kong J., Zhang Z., Musch M.W., et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am. J. Physiol. Gastrointest Liver Physiol. 294 (2008) G208-G216
53. Bartels L.E., Jorgensen S.P., Agnholt J., Kelsen J., Hvas C.L., and Dahlerup J.F. 1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease. Int. Immunopharmacol. 7 (2007) 1755-1764
54. Arslan G., Erichsen K., Milde A.M., Helgeland L., Bjorkkjaer T., Froyland L., and Berstad A. No protection against DSS-induced colitis by short-term pretreatment with seal or fish oils in rats. Integrative Med. Insights 2 (2007) 25-34